Bisphosphanates are used primarily for the prevention and treatment of osteoporosis, and are also indicated for osseous complications of malignancy. In addition to their bone resorption properties, ...

Bisphosphonates are medications that used to treat bone loss and are the most common agent to be prescribed for osteoporosis. These drugs can also reduce fracture risk in cases of previous fracture.

Bone tissue constitutes a fertile ‘soil’ for metastatic tumours, notably breast cancer. High concentrations of growth factors in bone matrix favour cancer cell proliferation and survival, and a ...

The American College of Physicians updated its 2017 guideline on pharmacologic treatment of osteoporosis or low bone mass to prevent fractures in adults. In a shift from previous recommendations, the ...

Compared with oral bisphosphonates, denosumab reduced fracture risk among treatment-experienced postmenopausal women with osteoporosis. Treatment with denosumab vs oral bisphosphonates is associated ...

BROOKLYN, NY — Authors of a new analysis say the US Food and Drug Administration (FDA) should consider revisiting its investigation of the atrial-fibrillation (AF) risk with certain osteoporosis drugs ...

The American College of Physicians’ new osteoporosis treatment guidelines support individualized medication plans, suggest an ideal length of therapy and take the clinical needs of seniors into ...

Labeling change adds warning about possible risks of long-term use of osteoporosis drugs The U.S. Food and Drug Administration today warned patients and health care providers about the possible risk ...

Please provide your email address to receive an email when new articles are posted on . “Although we observed an increasing number of osteonecrosis of the jaw cases in our daily practice during the ...

Long-term use of osteoporosis drugs seems to change bones in a way that could lead to unusual leg fractures, according to two reports presented at a meeting of orthopedic surgeons. Doctors have ...

Please provide your email address to receive an email when new articles are posted on . Older adults prescribed nitrogen-containing bisphosphonate therapy after a hip fracture were less likely to ...

So what sets this trial apart from the others? This study evaluated the utility of the second-generation bisphosphate pamidronate disodium as adjunctive therapy. Unlike many of the other trials ...